Chengdu Bright Eye Hospital Co. Ltd. (301239) - Net Assets
Based on the latest financial reports, Chengdu Bright Eye Hospital Co. Ltd. (301239) has net assets worth CN¥2.15 Billion CNY (≈ $314.35 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.74 Billion ≈ $694.16 Million USD) and total liabilities (CN¥2.60 Billion ≈ $379.81 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore balance sheet size of Chengdu Bright Eye Hospital Co. Ltd. for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.15 Billion |
| % of Total Assets | 45.29% |
| Annual Growth Rate | 18.55% |
| 5-Year Change | 117.96% |
| 10-Year Change | N/A |
| Growth Volatility | 42.81 |
Chengdu Bright Eye Hospital Co. Ltd. - Net Assets Trend (2019–2025)
This chart illustrates how Chengdu Bright Eye Hospital Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Check tangible equity quality of Chengdu Bright Eye Hospital Co. Ltd. to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Chengdu Bright Eye Hospital Co. Ltd. (2019–2025)
The table below shows the annual net assets of Chengdu Bright Eye Hospital Co. Ltd. from 2019 to 2025. For live valuation and market cap data, see market cap of Chengdu Bright Eye Hospital Co. Ltd..
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.07 Billion ≈ $302.46 Million |
-2.56% |
| 2024-12-31 | CN¥2.12 Billion ≈ $310.39 Million |
-8.50% |
| 2023-12-31 | CN¥2.32 Billion ≈ $339.23 Million |
+12.13% |
| 2022-12-31 | CN¥2.07 Billion ≈ $302.54 Million |
+118.02% |
| 2021-12-31 | CN¥948.30 Million ≈ $138.77 Million |
+11.14% |
| 2020-12-31 | CN¥853.25 Million ≈ $124.86 Million |
+14.64% |
| 2019-12-31 | CN¥744.32 Million ≈ $108.92 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Chengdu Bright Eye Hospital Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 20974265443.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥165.00 Million | 8.08% |
| Other Components | CN¥1.88 Billion | 91.92% |
| Total Equity | CN¥2.04 Billion | 100.00% |
Chengdu Bright Eye Hospital Co. Ltd. Competitors by Market Cap
The table below lists competitors of Chengdu Bright Eye Hospital Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Xian Peri Power Semiconductor Cond
SHE:300831
|
$710.35 Million |
|
Shanghai Yanpu Metal Products Co Ltd
SHG:605128
|
$710.61 Million |
|
Gerresheimer AG
F:GXI
|
$710.83 Million |
|
Gem-Year Industrial Co Ltd
SHG:601002
|
$710.89 Million |
|
Weikeng Industrial Co Ltd
TW:3033
|
$710.24 Million |
|
PWR Holdings Ltd
AU:PWH
|
$710.20 Million |
|
ZhuZhou QianJin Pharmaceutical Co Ltd
SHG:600479
|
$710.17 Million |
|
LSI Industries Inc
NASDAQ:LYTS
|
$710.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Chengdu Bright Eye Hospital Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,101,497,553 to 2,041,940,785, a change of -59,556,768 (-2.8%).
- Net loss of 60,922,620 reduced equity.
- Dividend payments of 17,751,826 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-60.92 Million | -2.98% |
| Dividends Paid | CN¥17.75 Million | -0.87% |
| Other Changes | CN¥19.12 Million | +0.94% |
| Total Change | CN¥- | -2.83% |
Book Value vs Market Value Analysis
This analysis compares Chengdu Bright Eye Hospital Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.38x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.89x to 2.38x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CN¥6.63 | CN¥32.44 | x |
| 2020-12-31 | CN¥7.60 | CN¥32.44 | x |
| 2021-12-31 | CN¥8.45 | CN¥32.44 | x |
| 2022-12-31 | CN¥13.82 | CN¥32.44 | x |
| 2023-12-31 | CN¥15.32 | CN¥32.44 | x |
| 2024-12-31 | CN¥14.05 | CN¥32.44 | x |
| 2025-12-31 | CN¥13.65 | CN¥32.44 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Chengdu Bright Eye Hospital Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.98%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.18%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 2.23x
- Recent ROE (-2.98%) is below the historical average (4.87%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 6.59% | 4.11% | 1.22x | 1.31x | CN¥-25.38 Million |
| 2020 | 12.77% | 8.00% | 0.66x | 2.43x | CN¥23.61 Million |
| 2021 | 9.90% | 5.49% | 0.74x | 2.45x | CN¥-940.79K |
| 2022 | 0.99% | 1.19% | 0.47x | 1.78x | CN¥-186.18 Million |
| 2023 | 11.69% | 9.86% | 0.56x | 2.10x | CN¥38.75 Million |
| 2024 | -4.85% | -3.80% | 0.58x | 2.19x | CN¥-312.01 Million |
| 2025 | -2.98% | -2.18% | 0.61x | 2.23x | CN¥-265.12 Million |
Industry Comparison
This section compares Chengdu Bright Eye Hospital Co. Ltd.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,730,875,343
- Average return on equity (ROE) among peers: 6.93%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Chengdu Bright Eye Hospital Co. Ltd. (301239) | CN¥2.15 Billion | 6.59% | 1.21x | $710.24 Million |
| Xian International Medical Investment Co Ltd (000516) | $703.26 Million | 8.41% | 1.49x | $1.40 Billion |
| Meinian Onehealth Healthcare Holdings Co Ltd (002044) | $3.24 Billion | 8.03% | 0.38x | $2.71 Billion |
| Hengkang Medical Group Co Ltd (002219) | $142.72 Million | 23.68% | 0.66x | $1.04 Billion |
| Aier Eye Hospital Group (300015) | $149.98 Million | 9.73% | 1.22x | $12.36 Billion |
| Liaoning He Eye Hospital Group Co. LTD. (301103) | $861.70 Million | 9.35% | 0.15x | $376.23 Million |
| Huaxia Eye Hospital Group Co. Ltd. A (301267) | $6.02 Billion | 7.12% | 0.32x | $2.04 Billion |
| Sanbo Hospital Management Group Ltd. A (301293) | $2.51 Billion | 3.12% | 0.25x | $1.61 Billion |
| Top Choice Medical Investment Co Inc (600763) | $216.22 Million | -14.03% | 0.09x | $2.41 Billion |
About Chengdu Bright Eye Hospital Co. Ltd.
Bright Eye Hospital Group Co., Ltd., a specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. Its ophthalmology institutions provide diagnosis, treatment, health care, medical optometry, glasses, and other general ophthalmic medical services for patients with ophthalmic diseases in the areas of refractive surgery, cataract, ophthal… Read more